Invacare Total Current Liabilities 2010-2023 | IVCRQ

Invacare total current liabilities from 2010 to 2023. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
Invacare Annual Total Current Liabilities
(Millions of US $)
2022 $220
2021 $247
2020 $230
2019 $219
2018 $198
2017 $218
2016 $221
2015 $248
2014 $290
2013 $276
2012 $300
2011 $288
2010 $290
2009 $290
Invacare Quarterly Total Current Liabilities
(Millions of US $)
2023-03-31 $196
2022-12-31 $220
2022-09-30 $223
2022-06-30 $228
2022-03-31 $233
2021-12-31 $247
2021-09-30 $230
2021-06-30 $245
2021-03-31 $222
2020-12-31 $230
2020-09-30 $233
2020-06-30 $278
2020-03-31 $297
2019-12-31 $219
2019-09-30 $202
2019-06-30 $194
2019-03-31 $191
2018-12-31 $198
2018-09-30 $200
2018-06-30 $199
2018-03-31 $212
2017-12-31 $218
2017-09-30 $201
2017-06-30 $208
2017-03-31 $209
2016-12-31 $221
2016-09-30 $225
2016-06-30 $233
2016-03-31 $235
2015-12-31 $248
2015-09-30 $248
2015-06-30 $264
2015-03-31 $273
2014-12-31 $290
2014-09-30 $290
2014-06-30 $268
2014-03-31 $270
2013-12-31 $276
2013-09-30 $257
2013-06-30 $259
2013-03-31 $263
2012-12-31 $300
2012-09-30 $280
2012-06-30 $281
2012-03-31 $293
2011-12-31 $288
2011-09-30 $298
2011-06-30 $305
2011-03-31 $279
2010-12-31 $290
2010-09-30 $287
2010-06-30 $280
2010-03-31 $264
2009-12-31 $290
2009-09-30 $269
2009-06-30 $268
2009-03-31 $290
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.000B $0.742B
Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the company designs, manufactures and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The company's products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.918B 20.77
Becton Dickinson (BDX) United States $66.130B 16.56
Cardinal Health (CAH) United States $30.812B 16.50
Straumann Holding AG (SAUHY) Switzerland $22.515B 0.00
Labcorp (LH) United States $21.029B 17.26
Cooper (COO) United States $17.974B 24.34
West Pharmaceutical Services (WST) United States $15.984B 32.75
Align Technology (ALGN) United States $14.238B 27.05
Henry Schein (HSIC) United States $9.680B 18.44
Merit Medical Systems (MMSI) United States $6.033B 30.81
DENTSPLY SIRONA (XRAY) United States $3.787B 10.30
Patterson (PDCO) United States $2.744B 14.66
CONMED (CNMD) United States $1.915B 14.90
STAAR Surgical (STAA) United States $0.800B 0.00
Lifevantage (LFVN) United States $0.211B 23.38
Pro-Dex (PDEX) United States $0.108B 16.47